International Journal of Clinical Case Reports 2024, Vol.14, No.2, 94-106 http://medscipublisher.com/index.php/ijccr 101 5.3 Public perception and acceptance of gene-edited organs Public perception and acceptance of gene-edited organs are crucial for the successful implementation of xenotransplantation technologies. The public's attitude towards gene editing in animals and its application in medical treatments can significantly influence regulatory policies and the adoption of these technologies. Studies indicate that public concerns primarily revolve around the ethical implications of genetic modifications and the potential risks associated with consuming genetically modified products or receiving gene-edited transplants. Transparency in the regulatory process and effective communication about the safety, benefits, and ethical considerations of gene editing are essential to gain public trust and acceptance (Rodriguez, 2016). Engaging the public in discussions about the ethical, legal, and social implications of gene editing can foster informed decision-making and promote a shared responsibility for the technology's development. Public engagement initiatives, such as consultations and forums, can help address societal concerns and build consensus on the acceptable uses of gene editing. 6 Challenges and Limitations 6.1 Technical challenges in CRISPR-Cas9 gene editing CRISPR-Cas9 technology, while revolutionary, faces several technical challenges that impact its efficacy and reliability. One of the primary challenges is the delivery of CRISPR components into target cells. Efficient delivery methods, such as viral vectors, liposomes, and electroporation, need to be optimized for different cell types and tissues to ensure successful gene editing (Kimberland et al., 2018). Additionally, the efficiency of homologous recombination for precise gene editing remains low, particularly in non-dividing cells, which limits the application of CRISPR-Cas9 for precise genetic modifications (Cao et al., 2016). Another significant challenge is the specificity of CRISPR-Cas9. Designing guide RNAs (gRNAs) that precisely target the desired DNA sequence without affecting similar sequences elsewhere in the genome is complex and requires thorough validation (Doench et al., 2015). The presence of single nucleotide polymorphisms (SNPs) can also affect the binding efficiency of gRNAs, necessitating personalized approaches for gene editing in therapeutic applications (Lessard et al., 2017). 6.2 Potential off-target effects and genetic stability One of the most critical concerns with CRISPR-Cas9 is its potential to cause off-target effects, which are unintended modifications in the genome that occur when the gRNA binds to similar but non-target sequences. These off-target mutations can lead to genomic instability and unintended phenotypic consequences, which are particularly concerning for clinical applications (Guo et al., 2023). Several strategies have been developed to minimize off-target effects, including the use of high-fidelity Cas9 variants (e.g., SpCas9-HF1), paired nickases, and truncated gRNAs, which increase the specificity of gene editing . Additionally, advanced methods such as Digenome-seq and VIVO (Verification of In Vivo Off-targets) are employed to detect and analyze off-target effects comprehensively (Kimberland et al., 2018). Despite these advancements, achieving complete genetic stability remains challenging. Continuous monitoring and validation of gene-edited organisms are required to ensure that off-target effects are minimized and do not compromise the intended therapeutic outcomes (Akçakaya et al., 2018). 6.3 Immunological complexities and long-term effects The immunological response to CRISPR-Cas9 components, particularly the Cas9 protein derived from bacteria, poses significant challenges. The human immune system can recognize and mount an immune response against Cas9, leading to reduced efficacy of gene editing and potential adverse effects (Zhang et al., 2015). This immunogenicity can limit the repeated use of CRISPR-Cas9 in therapeutic applications. Long-term effects of CRISPR-Cas9 gene editing also need to be thoroughly understood. While short-term studies have shown promising results, the long-term stability and safety of the edited genome require extensive evaluation.
RkJQdWJsaXNoZXIy MjQ4ODYzNQ==